Fatimah Gilani MD, FRCSC
Contact Info
Office Hours
- Today
- 8:00AM - 5:30PM
Fatimah Gilani MD, FRCSC
About Fatimah Gilani MD, FRCSC
Dr. Fatimah Gilani is a board-certified ophthalmologist both in Canada and the United States. Educated on three different continents, she has a diverse background, that provides an international perspective. Dr. Gilani is highly trained in the management of cataracts and refractive surgery procedures including EVO ICL. She also specializes in the management of age-related macular degeneration, diabetic retinopathy, and other vitreoretinal disorders.
Dr. Gilani began her career at the Royal College of Surgeons in Ireland and subsequently completed her medical internship at the Baystate Medical Center, a hospital affiliated with Tufts University in Springfield, Massachusetts. She completed her ophthalmology residency at the University of Arizona, followed by a medical retina fellowship at Northwell Long Island Jewish Hospital and the Vitreous Retina Consultants of New York under the tutelage of world-renowned retina specialists Dr. Lawrence Yannuzzi, Dr. K Bailey Freund, Dr. William Schiff and Dr. Gaetano Barile.
Dr. Gilani is actively involved with clinical research and has written a number of published journal and magazine articles. She grew up in Kenya and throughout her medical career has maintained an interest in alleviating blindness in developing countries and has participated in charitable work in Kenya, Pakistan, Vietnam, Mexico and Honduras. She sits on the Board of Directors for Operation Eyesight Canada.
“As an ophthalmologist, seeing the difference the gift of sight makes in someone’s life is the most rewarding part of my job,” Dr. Gilani says. “I’m excited to be joining a global community that impacts not only the lives of individuals, but entire communities, regions and countries.” - Dr Gilani
Photos of Fatimah Gilani MD, FRCSC

Select Your Region
Latin America
References
1. Patient Survey, STAAR Surgical ICL Data Registry, 2018
2. Sanders D. Vukich JA. Comparison of implantable collamer lens (ICL) and laser-assisted in situ keratomileusis (LASIK) for Low Myopia. Cornea. 2006 Dec; 25(10):1139-46. Patient Survey, STAAR Surgical ICL Data Registry, 2018
3. Naves, J.S. Carracedo, G. Cacho-Babillo, I. Diadenosine Nucleotid Measurements as Dry-Eye Score in Patients After LASIK and ICL Surgery. Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2012.
4. Shoja, MR. Besharati, MR. Dry eye after LASIK for myopia: Incidence and risk factors. European Journal of Ophthalmology. 2007; 17(1): pp. 1-6.
5a. Lee, Jae Bum et al. Comparison of tear secretion and tear film instability after photorefractive keratectomy and laser in situ keratomileusis. Journal of Cataract & Refractive Surgery , Volume 26 , Issue 9 , 1326 - 1331.
5b. Parkhurst, G. Psolka, M. Kezirian, G. Phakic intraocular lens implantantion in United States military warfighters: A retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481.
Important Safety Information
The EVO/EVO+ ICLs are indicated for patients who are 21 to 60 years of age and are available in spherical powers ranging from -3.0 D to -18.0 D for the correction/reduction of myopia with or without a cylinder power range from 1.0 D to 6.0 D. The hyperopic ICLs are indicated for patients who are 21 to 45 years of age and are available in powers ranging from +3.0 D to +10.0 D for the correction/reduction of hyperopia. In order to be sure that your surgeon will use an ICL with the most adequate power for your eye, your nearsightedness, farsightedness and astigmatism should be stable for at least a year before undergoing eye surgery. ICL surgery may improve your vision without eyeglasses or contact lenses. ICL surgery does not eliminate the need for reading glasses, even if you have never worn them before. ICL represents an alternative to other refractive surgeries including, laser assisted in situ keratomileusis (LASIK), photorefractive keratectomy (PRK), incisional surgeries, or other means to correct your vision such as contact lenses and eye glasses. Implantation of an ICL is a surgical procedure, and as such, carries potentially serious risks. The following represent potential complications/ adverse reactions reported in conjunction with refractive surgery in general: additional surgeries, cataract formation, loss of best corrected vision, raised pressure inside the eye, loss of cells on the innermost surface of the cornea, conjunctiva I irritation, acute corneal swelling, persistent corneal swelling, endophthalmitis (total eye infection), significant glare and/or halos around lights, hyphaema (blood in the eye), hypopyon (pus in the eye), eye infection, ICL dislocation, macular oedema, non-reactive pupil, pupillary block glaucoma, severe inflammation of the eye, iritis, uveitis, vitreous loss and corneal transplant. Before considering ICL surgery you should have a complete eye examination and talk with your eye care professional about ICL surgery, especially the potential benefits, risks, and complications. You should discuss the time needed for healing after surgery.